Firmenich is unveiling the first innovation to come out of its
newly formed nutrition and health unit - Duralife Omega 3, which
uses microencapsulation technology to overcome stability issues of
working with the healthful ingredient.
A Maryland court has ruled in favor of Martek Biosciences in a
motion of summary judgment of an outstanding dispute with the
former interest holders of OmegaTech, the DHA producer it acquired
in March 2002.
Omega-3 and -6 fatty acids and vitamin E in the diet could slash
the risk of motor neurone disease (MND) by 60 per cent, say new
research from the Netherlands.
A Mediterranean-style diet, rich in olive oil, fresh vegetables and
vitamin E, could reduce the risk of obstructions in blood vessels
in the elderly, says Italian research.
SharpPS gold, a PS-DHA conjugate from Israeli company Enzymotec, is
being used in a US supplement for the first time with the
reformulation of Cognitex from Life Extension.
Arcadia Biosciences has announced the development of 65 percent
gamma linolenic acid (GLA) safflower seed oil - a development that
will make available a new, economical source of the omega-6 fatty
acid and shake up safflower production...
While omega 3 supplements or enriched foods are on the rise, so too
are the clinical trials that are boosting the scientific foundation
and exploring new applications.
Nutri Pharmaceuticals Research (NPRI) has reported a record first
quarter 2006, with sales of its oil powders up 45 percent on last
year's period to $421,000 as business development initiatives pay
off.
The European inventors of a process for deriving higher yields of
DHA (docosahexaenoic acid) from microalgae have licensed the patent
to Advanced BioNutrition - a deal that could ultimately impact the
human nutrition market for DHA.
Boots has become the second UK company to withdraw fish oil
supplements from the market due to excessive dioxin levels in less
than a month, but companies and the authorities reassure consumers
that the products pose no threat to...
Leatherhead Food International is offering a new analysis service
to help food manufacturers develop products with added omega-3 and
to aid quality control.
Omega-3 fatty acids could prevent or inhibit the growth of liver
cancer cells, say researchers from the University of Pittsburgh at
today's annual meeting of the American Association for Cancer
Research.
Norwegian researchers are developing a new chewable capsule for
omega-3, primarily aimed at small children who have trouble
swallowing normal capsules.
Israeli biofunctional ingredients maker Enzymotec is continuing its
Eastern European expansion with a move into Russia with its
phosphatidylserine (PS)-containing brain health products.
The omega-3 market is one of the biggest trends in the supplement
market today, but it seems it is crossing from general wellness
towards products aimed at specific consumers and indications.
Denomega Nutritional Oils and GAT Food Essentials have joined
forces to take on the European functional food and beverage market,
leveraging the former's fresh oils and the latter's
microencapsulation technology.
Intake of omega-3 fatty acids from oily fish and fish oil
supplements has no effect on mortality, heart disease or cancer,
concludes a new review, but guidelines should continue for
consumption.
Eating a diet with omega-3-rich oily fish could stop the spread of
prostate cancer, but omega-6 fatty acids appear to promote the
spread, says new research.
Martek Biosciences is seeking to open up uses of its algae derived
DHA, with a new microencapsulated powder for use in foods and
drinks that require dry mixing.
Ocean Nutrition Canada (ONC) is launching a new version of Meg-3
with an higher ratio of DHA:EPA that will help companies develop
products for young mothers concerned about infant nutrition.
A new Swiss company is claiming to have found a way to derive
omega-3 containing both EPA and DHA from algae, which could place
suppliers whose product is derived from fish oil under price
pressure.
Ocean Nutrition Canada has signed a trademark licensing agreement
with Australia's YourHealth Group for the use of its Meg-3 omega-3
brand on complementary medicines.
Global fish oil production declined in 2005, according to figures
from the US fisheries department, while demand from the
nutraceuticals industry is on the up.
Neptune Technologies & Bioressources has announced that it has
overcome the barriers to developing functional foods using Neptune
Krill Oil (NKO) in alliance with Terepia, with the introduction of
three fruit-flavored custards.
Martek Biosciences continued its recovery from the impact of
stockpiling in first quarter 2006 with a better-than-expected set
of results thanks to its infant formula clients rolling out
products on a global basis.
A new pilot study gets underway today to assess the effect of fish
oil supplements in children at a residential school who have
experienced severe emotional, behavioural and social difficulties.
PBM Products has launched what it claims to be the first organic
baby formula containing the omega-3 fatty acid DHA and the omega-6
fatty acid ARA for nationwide distribution in the US.
Decas Cranberry Products (DCP) has fortified sweetened organic
cranberries with omega-3 - an enhancement that could help
formulators improve the nutritional profile of foods.
Norwegian omega-3 producer Epax has announced it has de-mergered
from its parent company Pronova Biocare, after experiencing 25 per
cent growth for 2005.
PBM Products have launched the GlucoBurst drink, fortified with
beta-carotene and omega-3 DHA specially formulated to enter the
$120m US diabetic nutritional market.
The benefits of omega-3, protein, and essential vitamins and
minerals from oily fish outweigh the risks of pollutants, say
American experts, as British scientists find pollutant levels are
falling.
Norway's Denomaga is seeking to gain a large slice of the UK
omega-3 market and has signed an agreement with S Black for the
distribution of its oils to the food, beverage, health care and
nutraceuticals sectors.
A low-carbohydrate diet results in more weight loss after six
months than a low-fat diet, but long term could raise bad
cholesterol and increase the risk of heart disease, claims a
meta-analysis.
Five servings of fruit and vegetables per day and a diet low in fat
reduced the risk of breast cancer by nine per cent, a figure
dismissed as not significant and due to 'chance'.
Eating less fat and more fruit and vegetables has no effect on the
risk of cardiovascular disease (CVD), claims a long-term dietary
intervention study claimed to be the largest ever conducted - a
conclusion that is inconsistent with...
Omega-3 may be a hot topic on everyone's lips, but the industry
still needs to overcome negative perceptions about traditional
sources such as oily fish, according to research analysis by Frost
and Sullivan.
People with type-1 diabetes should switch to a low-fat diet,
scientists have recommended after showing that the metabolism of a
diabetic heart is affected by high blood fat levels.
Taking vitamin E and selenium supplements could reduce the toxicity
of mercury from fish, indicates an animal study. If replicated in
humans, the findings may mean pregnant women could consume more
fish, and their babies benefit from...
A new statement on diet from the American Heart Association
emphasises weight loss, cutting back on salt and alcohol and
increasing dietary potassium as viable ways to reduce blood
pressure, but does not recommend the use of supplements.
Researchers from Bristol have been awarded almost £9 million (€13
million)to continue research into child nutrition, a study that has
already delivered glowing results for omega-3.
Increasing sales of NKO and a tight hold on the purse strings are
helping Neptune Technologies on its way to profitability. The
Canadian biotech reduced its loses in the second by 25 percent to
$380,000, while sales rose 22 percent...
IOI-Loders Croklaan division Lipid Nutrition has strengthened its
position in the world CLA market with the acquisition of
PharmaNutrients' CLA One business.
Swiss chemicals group Lonza has reported a 38.8 percent increase in
operating income in 2005, but margins for its nutritional products
have been eroded by high costs.
A new review study has poured water on claims that there is
sufficient evidence to support a link between omega-3 consumption
and a reduced risk of cancer.
Nutritional powders supplier Nutri Pharmaceuticals Research will
introduce a range of products with higher bioavailability thanks to
a technology based on aloe vera.
Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...
INNOBIO provides innovative solutions for women to overcome a variety of health challenges throughout the life cycle, from emotional health, PMS management,...
Omega-3 long-chain polyunsaturated fatty acids (PUFAs) have numerous positive health benefits and are among the most extensively studied micronutrients....